Subsequent Events	6 Months Ended
Jun. 30, 2017
Notes
Subsequent Events	1. Subsequent Events We have evaluated subsequent events through the date of issuance of the unaudited consolidated financial statements, and below are the material recognizable subsequent events. · In October 2017, the Company issued 13,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance. · In June 2017, the Company issued 15,000,000 shares of common stock at an average price of $0.0003 per share to a firm resolving debt of the Company under a 3(a)10 filing. · In June 2017, the Company issued 562,333,333 shares of common stock at an average price of $0.0002 per share (the share price at the time of issuance) to consultants who are also accredited investors. · In January 2018, the Company issued 5,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance. · In April 2018, the Company issued 7,500,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance. · In June 2018, the Company issued 275,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance. · In July 2018, the Company issued 42,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance. · In August 2018, the Company issued 555,000,000 shares of common stock to employees in payment of accrued pay and as bonuses for their services. The shares were issued at the market price on the date of issuance. · In September 2018, the Company issued 9,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price of $0.009 per share.

Subsequent Events

6 Months Ended

Jun. 30, 2017

1. Subsequent Events

We have evaluated subsequent events through the date of issuance of the unaudited consolidated financial statements, and below are the material recognizable subsequent events.

· In October 2017, the Company issued 13,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance.

· In June 2017, the Company issued 15,000,000 shares of common stock at an average price of $0.0003 per share to a firm resolving debt of the Company under a 3(a)10 filing.

· In June 2017, the Company issued 562,333,333 shares of common stock at an average price of $0.0002 per share (the share price at the time of issuance) to consultants who are also accredited investors.

· In January 2018, the Company issued 5,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance.

· In April 2018, the Company issued 7,500,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance.

· In June 2018, the Company issued 275,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance.

· In July 2018, the Company issued 42,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price on the date of issuance.

· In August 2018, the Company issued 555,000,000 shares of common stock to employees in payment of accrued pay and as bonuses for their services. The shares were issued at the market price on the date of issuance.

· In September 2018, the Company issued 9,000,000 shares of common stock to consultants in exchange for their services. The shares were issued at the market price of $0.009 per share.

EASTGATE BIOTECH CORP 10-Q